An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum
- 15 September 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (18) , 3075-3077
- https://doi.org/10.1016/0006-2952(87)90226-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Determination of Endogenous Acetylcholine Release in Freely Moving Rats by Transstriatal Dialysis Coupled to a Radioenzymatic Assay: Effect of DrugsJournal of Neurochemistry, 1987
- Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepineLife Sciences, 1987
- A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypesLife Sciences, 1983
- Central administration of the muscarinic receptor subtype - selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouseJournal of Pharmacy and Pharmacology, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- Studies on the indirect feedback inhibition of cholinergic neurons triggered by oxotremorine in striatumBrain Research, 1981
- Pirenzepine distinguishes between different subclasses of muscarinic receptorsNature, 1980
- The effect of cholinergic drugs on [3H]acetylcholine release from slices of rat hippocampus, striatum and cortexBrain Research, 1977
- Increase in striatal acetylcholine by picrotoxin in the rat: Evidence for a gabergic-dopaminergic-cholinergic linkBrain Research, 1976
- Action of opiates, antipsychotics, amphetamine and apomorphine on dopamine receptors in rat striatum: in vivo changes of 3′,5′-cyclic amp content and acetylcholine turnover rateNeuropharmacology, 1975